Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             155 results found
no title author magazine year volume issue page(s) type
1 ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation 2006
5 p. 697-702
article
2 Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients 2006
5 p. 651-652
article
3 Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas Behl, Deepti
2007
5 p. 409-415
article
4 Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia Landgren, Ola
2007
5 p. 791-798
article
5 A four base pair insertion in exon 1 of the RPS19 gene is a common polymorphism in African-Americans Huang, Quillan
2006
5 p. 745-746
article
6 Age-dependent accumulation of monoclonal CD4+CD8+double positive T lymphocytes in the peripheral blood of the elderly Ghia, Paolo
2007
5 p. 780-790
article
7 Analysis of immunoglobulin VH genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens Bahler, David W.
2006
5 p. 571-575
article
8 Anion exchanger 2 mediates the action of arsenic trioxide Pan, Xiao-Yan
2006
5 p. 491-499
article
9 Announcement of the 12th Congress Of The European Hematology Association 7–10 June, 2007, Vienna, Austria 2007
5 p. 766
article
10 A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4+ T cells to skin in human graft-versus-host disease Faaij, Claudia M. J. M.
2006
5 p. 538-549
article
11 A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing Gardiner, Chris
2006
5 p. 598-603
article
12 A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO Bolton-Maggs, Paula H. B.
2006
5 p. 603-633
article
13 A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma Glasmacher, Axel
2006
5 p. 584-593
article
14 Author index 2006
5 p. 750-753
article
15 B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred Abbasi, Fatima
2007
5 p. 820-823
article
16 B cells behaving badly Shim, Youn K.
2007
5 p. 658-662
article
17 Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation Hardy, Nancy M.
2007
5 p. 824-831
article
18 Biomolecular characterisation of leucocytes by infrared spectroscopy Liu, Kan-Zhi
2007
5 p. 713-722
article
19 Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I 2006
5 p. 456
article
20 Bone marrow trephine biopsy appearances of the intravascular subtype of diffuse large B-cell lymphoma Thomson, Jennifer J.
2007
5 p. 683
article
21 Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma Terpos, Evangelos
2006
5 p. 688-692
article
22 British Society for Haematology/Lifeblood/British Society for Haemostasis and Thrombosis Joint Award 2006
5 p. 552
article
23 Carotid intima-media thickness is increased and related to arterial stiffening in patients with beta-thalassaemia major Cheung, Y. F.
2006
5 p. 732-734
article
24 Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation Gerovassili, Ageliki
2006
5 p. 738-741
article
25 Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap Smulders, Y. M.
2006
5 p. 623-629
article
26 cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy Valente, Guido
2006
5 p. 560-570
article
27 Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease * Kaplan, Batia
2007
5 p. 723-728
article
28 Chemical exposures and risk of chronic lymphocytic leukaemia Blair, Aaron
2007
5 p. 753-761
article
29 Chronic eosinophilic leukaemia with FIP1L1–PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy Ohnishi, Hiroaki
2006
5 p. 547-549
article
30 Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature Schubauer-Berigan, Mary K.
2007
5 p. 799-808
article
31 Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology Dores, Graça M.
2007
5 p. 809-819
article
32 Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis Linet, Martha S.
2007
5 p. 672-686
article
33 Chronic lymphocytic leukaemia genetics overview Caporaso, Neil
2007
5 p. 630-634
article
34 Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review Baldus, Claudia D.
2007
5 p. 387-400
article
35 Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with l-asparaginase: an in vitro study Kuhle, Stefan
2006
5 p. 526-531
article
36 Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time Lasho, Terra L.
2006
5 p. 683-687
article
37 Constitutively activated FLT3 phosphorylates BAD partially through Pim-1 Kim, Kyu-Tae
2006
5 p. 500-509
article
38 Correction of severe anaemia using immuno-regulated gene therapy is achieved by restoring the early erythroblast compartment Du  Roure, Camille
2006
5 p. 608-614
article
39 Corrigendum 2006
5 p. 665
article
40 Corrigendum 2006
5 p. 662
article
41 Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia – The Hunting of the Snark? Shapiro, Howard M.
2007
5 p. 772-773
article
42 Differential cell division history between neutrophils and macrophages in their development from granulocyte–macrophage progenitors Sugimoto, Yuka
2006
5 p. 725-731
article
43 Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration Nadav, Liat
2006
5 p. 530-532
article
44 Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases 2006
5 p. 655-656
article
45 Down syndrome and acute lymphoblastic leukaemia Whitlock, James A.
2006
5 p. 595-602
article
46 Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission Pavlu, Jiri
2007
5 p. 423-428
article
47 Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman Disease Hess, Georg
2006
5 p. 544-545
article
48 Emerging therapy for chronic lymphocytic leukaemia Auer, Rebecca L.
2007
5 p. 635-644
article
49 Eosinophilia: secondary, clonal and idiopathic Tefferi, Ayalew
2006
5 p. 468-492
article
50 Erratum 2006
5 p. 664
article
51 Erratum 2006
5 p. 747
article
52 Erratum 2007
5 p. 765
article
53 Erratum 2006
5 p. 550
article
54 Erratum 2006
5 p. 663
article
55 Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? Prutchi-Sagiv, Sara
2006
5 p. 660-672
article
56 Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours Goldin, Lynn R.
2007
5 p. 774-779
article
57 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma Odawara, Jun
2007
5 p. 684
article
58 Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma Hosing, Chitra
2006
5 p. 533-537
article
59 Globin gene expression in Hb Lepore-BAC transgenic mice Sloane-Stanley, Jackie
2006
5 p. 735-737
article
60 Guidelines on the management of massive blood loss Stainsby, D.
2006
5 p. 634-641
article
61 Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project Bennett, Charles L.
2006
5 p. 642-650
article
62 Haemoglobin H hydrops fetalis syndrome associated with homozygosity for the α2-globin gene polyadenylation signal mutation AATAAA→AATA– – Henderson, Shirley
2006
5 p. 743-745
article
63 High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study Mannone, L.
2006
5 p. 513-519
article
64 Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation Leytin, V.
2007
5 p. 762-764
article
65 Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections Renella, Raffaele
2006
5 p. 510-516
article
66 Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease Bishton, Mark J.
2007
5 p. 752-761
article
67 Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia Giralt, Sergio A.
2007
5 p. 461-467
article
68 Inconsistencies in the association between JAKV617F mutation and PRV-1 over-expression among the chronic myeloproliferative disorders – response to Vannucchi et al 2006
5 p. 654
article
69 Inconsistencies in the association between the JAK2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 2006
5 p. 652-654
article
70 Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia Papadaki, Helen A.
2006
5 p. 637-639
article
71 Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia Meisel, Roland
2007
5 p. 457-460
article
72 In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy 2006
5 p. 656-658
article
73 In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy – response to Prentice et al 2006
5 p. 658-659
article
74 Insights into von Willebrand factor proteolysis: clinical implications Bowen, D. J.
2006
5 p. 457-467
article
75 International Conference on Emerging Trends in Haematology and Immunohaematology 2006
5 p. 749
article
76 Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages Porat, Yael
2006
5 p. 703-714
article
77 Joe Burchenal and the birth of combination chemotherapy Thomas, Angela
2006
5 p. 493-503
article
78 Keyword index 2006
5 p. 754-756
article
79 Leukaemic infiltration of the retina at onset of Philadelphia-positive acute lymphoblastic leukaemia revealed by stratus optical coherence tomography 2006
5 p. 455
article
80 Localisation of proteins of iron metabolism in the human placenta and liver Bastin, Judy
2006
5 p. 532-543
article
81 Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue Nolan, L.
2007
5 p. 436-442
article
82 Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance Pepe, Jessica
2006
5 p. 485-490
article
83 Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab Wanner, Kathrin
2006
5 p. 475-484
article
84 Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research Panepinto, Julie A.
2007
5 p. 479-485
article
85 Maternal plasma or human serum albumin in wash buffer enhances enrichment and ex vivo expansion of human umbilical cord blood CD34+ cells Kwok, Yvonne K.
2007
5 p. 468-474
article
86 MDR1 polymorphism influences the outcome of multiple myeloma patients Buda, Gabriele
2007
5 p. 454-456
article
87 Mediterranean stomatocytosis/macrothrombocytopenia: update from Adelaide, Australia 2006
5 p. 660-661
article
88 Megakaryocyte development and platelet production Deutsch, Varda R.
2006
5 p. 453-466
article
89 Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT Hofman, Michael S.
2007
5 p. 386
article
90 MicroRNAs in the pathogeny of chronic lymphocytic leukaemia Nicoloso, Milena S.
2007
5 p. 709-716
article
91 Modern management of non-Hodgkin lymphoma in HIV-infected patients Mounier, Nicolas
2007
5 p. 685-698
article
92 Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes Plass, Christoph
2007
5 p. 744-752
article
93 Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies Vogt, Robert F.
2007
5 p. 690-700
article
94 Monoclonal B-cell lymphocytosis in blood donors Rachel, Jane M.
2007
5 p. 832-836
article
95 Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression Kyle, Robert A.
2007
5 p. 730-743
article
96 MRCPath Haemostasis Training and Update 2006
5 p. 668
article
97 Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases Landgren, Ola
2007
5 p. 717-723
article
98 Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model Scaglione, Brian J.
2007
5 p. 645-657
article
99 Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells Deriano, Ludovic
2006
5 p. 520-525
article
100 Myeloid lineage-selective growth of revertant cells in Fanconi anaemia Hamanoue, Satoshi
2006
5 p. 630-635
article
101 Nodular sclerosing Hodgkin disease presenting as a sternal mass Priola, Sandro M.
2006
5 p. 594
article
102 Novel mutations in a child with congenital amegakaryocytic thrombocytopenia Pemberton, Lucy C.
2006
5 p. 742-743
article
103 Novo Nordisk Haemophilia Foundation website 2006
5 p. 551
article
104 Novo Nordisk Haemophilia Foundation website 2006
5 p. 748
article
105 Obtaining consent for chemotherapy Treleaven, J.
2006
5 p. 552-559
article
106 Osteopontin: a bridge between bone and blood Haylock, David N.
2006
5 p. 467-474
article
107 Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience Rawstron, Andy C.
2007
5 p. 845-848
article
108 Overview of monoclonal B-cell lymphocytosis Marti, Gerald
2007
5 p. 701-708
article
109 Overview of monoclonal gammopathies of undetermined significance Vogt, Robert F.
2007
5 p. 687-689
article
110 Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells Bacher, Nicole
2006
5 p. 615-622
article
111 Papers to be published in forthcoming issues 2006
5 p. x
article
112 Papers to be published in forthcoming issues 2006
5 p. xii
article
113 Papers to be published in forthcoming issues 2006
5 p. x
article
114 Papers to be published in forthcoming issues 2006
5 p. xii
article
115 Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used Ings, Stuart J.
2006
5 p. 517-525
article
116 Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy Österborg, Anders
2007
5 p. 736-744
article
117 Plasmacytoma in a multiple myeloma patient Jablonski, Mathieu
2006
5 p. 451
article
118 Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy Sarode, Ravindra
2006
5 p. 604-607
article
119 Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors Goldman, John M.
2006
5 p. 651-652
article
120 Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings Kobayashi, Ryoji
2006
5 p. 693-696
article
121 Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells Brueckmann, Martina
2006
5 p. 550-557
article
122 Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan Mori, Tetsuya
2006
5 p. 594-597
article
123 Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia Johnson, Amy J.
2007
5 p. 837-844
article
124 Robin Coombs: his life and contribution to haematology and transfusion medicine Pamphilon, Derwood H
2007
5 p. 401-408
article
125 Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma Richardson, Paul G.
2007
5 p. 429-435
article
126 Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Lalazar, Gadi
2007
5 p. 699-712
article
127 Second international symposium on childhood, adolescent and young adult non-Hodgkin lymphoma 2006
5 p. 667
article
128 Sequential fluorescence in situ hybridisation analysis for cryptic t(11;14)(q13;q32) in mantle cell lymphoma Gazzo, Sophie
2006
5 p. 452
article
129 Serum cancer antigen 15-3 concentrations in patients with sickle cell disease Boga, Can
2006
5 p. 546-547
article
130 Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status Yeh, Howard S.
2006
5 p. 526-529
article
131 Shwachman–Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis Leung, Elaine W.
2006
5 p. 558-561
article
132 Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-β/BMP pathway Nolan, Vikki G.
2006
5 p. 570-578
article
133 Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia Dalal, Bakul I.
2007
5 p. 385
article
134 Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns Hughes, Marie
2007
5 p. 486-487
article
135 Somatic hypermutation and VH gene usage in hairy cell leukaemia Arons, Evgeny
2006
5 p. 504-512
article
136 Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma Grogg, Karen L.
2007
5 p. 416-422
article
137 Stage specific gene expression of serpins and their cognate proteases during myeloid differentiation Missen, Melinda A.
2006
5 p. 715-724
article
138 Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab Au, Wing-Yan
2007
5 p. 475-478
article
139 Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma Porreca, Ettore
2006
5 p. 593
article
140 Susceptibility genes and B-chronic lymphocytic leukaemia Slager, Susan L.
2007
5 p. 762-771
article
141 t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt Imai, Norikazu
2006
5 p. 673-682
article
142 T-cell lymphoblastic lymphoma presenting as an intra-muscular mass 2006
5 p. 537
article
143 Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans Mele, Anna
2007
5 p. 729-735
article
144 Thalassaemia-like carriers not linked to the β-globin gene cluster Faà, Valeria
2006
5 p. 640-650
article
145 The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia Rawstron, Andy C.
2007
5 p. 724-729
article
146 The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells Rovida, Elisabetta
2006
5 p. 653-659
article
147 The CLL Issue Cotter, Finbarr E
2007
5 p. 629
article
148 The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders Larsen, Thomas Stauffer
2007
5 p. 745-751
article
149 The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish Auer, Rebecca L.
2007
5 p. 443-453
article
150 Third Annual ICH/GOSH Paediatric Haematology–Oncology Symposium 2006
5 p. 666
article
151 Towards targeted therapy for infant acute lymphoblastic leukaemia Stam, Ronald W.
2006
5 p. 539-551
article
152 Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials Rao, Anupama
2006
5 p. 576-583
article
153 Unusual abdominal manifestations of catastrophic antiphospholipid syndrome 2006
5 p. 538
article
154 von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation Hollestelle, Martine J.
2006
5 p. 562-569
article
155 Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition McMaster, Mary L.
2007
5 p. 663-671
article
                             155 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands